ECFC-Based Prediction of Individual Sensitivity to Low-Dose Ionizing Radiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective quantitative measures to determine individual sensitivity to low-dose ionizing radiation, which is a significant concern due to its association with increased cancer and other disease risks from medical procedures like CT-scans, as traditional methods like peripheral blood lymphocyte studies face limitations in proliferation potential and signal-to-noise ratio.
Innovation Solution
Isolating and growing progenitor cells, specifically Endothelial Colony-Forming Cells (ECFCs), and evaluating their viability, proliferation, and differentiation in response to low-dose ionizing radiation to predict individual sensitivity, using a database to compare results and determine relative sensitivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If peripheral blood lymphocytes are used to study individual responses to LDIR, then individual sensitivity can be assessed, but the method suffers from low proliferation potential, low signal-to-noise ratio, and transience of measured response indicators
Solution Approach 1:
The patent changes the cell type parameter from peripheral blood lymphocytes to endothelial colony-forming cells (ECFCs), which exhibit higher proliferation potential and more stable response indicators. This parameter change resolves the contradiction by selecting a cell population that naturally possesses both high proliferative capacity and reliable, measurable responses to LDIR exposure.
2Measurement precision
If quantitative measures of individual response to LDIR are developed, then sensitivity prediction improves, but direct experimentation on human populations is not feasible
Solution Approach 1:
The patent creates in vitro copies of human endothelial cells (ECFCs) that can be cultured and exposed to LDIR in controlled laboratory settings. These cell copies serve as proxies for studying human response to radiation without requiring direct experimentation on human populations, thus resolving the contradiction between measurement precision and experimental feasibility.
3Loss of information
If traditional methods are used to assess LDIR sensitivity, then individual variation can be detected, but the transience of measured response indicators limits utility
Solution Approach 1:
The patent employs ECFCs that inherently maintain stable, long-lasting response indicators through their natural biological properties. These cells self-maintain measurable markers of radiation response over extended periods without requiring external stabilization or frequent re-measurement, thus resolving the contradiction between information loss and measurement precision.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method allows for predicting individual sensitivity to low-dose ionizing radiation, enabling informed decisions on exposure to radiation from procedures like CT-scans, thereby potentially reducing cancer and other disease risks by identifying those most sensitive.
Implementation Method 1
exposing the patient cells to LDIR; evaluating the effect of the LDIR on the isolated patient cells by measuring the change in at least one of the group comprising viability, proliferation and differentiation of the patient cells
Data Source
AI summary
The present invention relates to the innovation that ECFCs are a predictor of the likely result to the exposure of a patient to low dose ionizing radiation by comparing the results of exposure of cells to individuals already exposed to ECFCs.